Nerve growth factor protects R2 cells against neurotoxicity induced by methamphetamine

Toxicology Letters

Volumn 150, Issue 2, 2004, Pages 221-227

  Zhou, Jun Lan ^a   Liang, Jian Hui ^a   Zheng, Ji Wang ^a   Li, Chang Ling ^b  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Apoptosis; Methamphetamine; Nerve growth factor; Neurotoxicity

Indexed keywords

DNA FRAGMENT; METHAMPHETAMINE; NERVE GROWTH FACTOR; NEUROPROTECTIVE AGENT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ASSAY; CELL DEATH; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; MALE; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; CELL LINE; CELL SURVIVAL; CEREBELLUM; FLOW CYTOMETRY; METHAMPHETAMINE; MICE; NERVE GROWTH FACTOR; NEUROPROTECTIVE AGENTS; RATS;

CRYPTOGRAPHIC PROTOCOLS; FREE-ROAMING AGENTS; MOBILE AGENTS; SECURE ELECTRONIC COMMERCE;

CRYPTOGRAPHY; DATA PRIVACY; NETWORK PROTOCOLS; SOFTWARE AGENTS; SOFTWARE ENGINEERING;

ELECTRONIC COMMERCE;

EID: 10444226576     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2004.01.007     Document Type: Article

References (24)

1. Barde Y.A. Trophic factors and neuronal survival. Neuron. 2:1989;1525-1534.
2. Bowyer J.F., Clausing P., Gough B., Slikker W. Jr., Holson R.R. Nitric oxide regulation of methamphetamine-induced dopamine release in caudate/putamen. Brain Res. 699:1995;62-70.
3. Brown P., Molliver M.E. Dual serotonin (5-HT) projections to the nucleus accumbens core and shell: relation of the 5-HT transporter to amphetamine-induced neurotoxicity. J. Neurosci. 20:2000;1952-1963.
4. Cadet J.L., Brannock C. Free radicals and the pathobiology of brain dopamine systems. Neurochem. Int. 32:1998;117-131.
5. Cadet J.L., Ordonez S.V., Ordonez J.V. Methamphetamine induces apoptosis in immortalized neural cells: protection by the proto-oncogene, bcl-2. Synapse. 25:1997;176-184.
6. Chalfie M., Wolinsky E. The identification and suppression of inherited neurodegeneration in Caenorhabditis elegans. Nature. 345:1990;410-416.
7. Cubells J.F., Rayport S., Rajendran G., Sulzer D. Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14:1994;2260-2271.
8. Deng X., Cai N.S., McCoy M.T., Chen W., Trush M.A., Cadet J.L. Methamphetamine induces apoptosis in an immortalized rat striatal cell line by activating the mitochondrial cell death pathway. Neuropharmacology. 42:2002;837-845.
9. Deng X., Wang Y., Chou J., Cadet J.L. Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method. Brain Res. Mol. Brain Res. 93:2001;64-69.
10. De Vito M.J., Wagner G.C. Methamphetamine-induced neuronal damage: a possible role for free radicals. Neuropharmacology. 28:1989;1145-1150.
11. Ernst T., Chang L., Leonido-Yee M., Speck O. Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study. Neurology. 54:2000;1344-1349.
12. Graham D.G., Tiffany S.M., Bell W.R. Jr., Gutknecht W.F. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14:1978;644-653.
13. Gu J.J., Ming H., Huang B.R., Cai L.W. Expression of human low-affinity nerve growth factor receptor in mammalian neural cells and its induction of apoptosis. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 29:1997;343-350.
14. Guegan C., Ceballos-Picot I., Chevalier E., Niconle A., Onteniente B., Sola B. Reduction of ischemic damage in NGF-transgenic mice: correlation with enhancement of antioxidant enzyme activities. Neurobiol. Dis. 6:1999;180-189.
15. Hom D.G., Jiang D., Hong E.J., Mo J.Q., Andersen J.K. Elevated expression of glutathione peroxidase in PC12 cells results in protection against methamphetamine but not MPTP toxicity. Brain Res. Mol. Brain Res. 46:1997;154-160.
16. Huang B.R., Gu J.J., Ming H., Lai D.B., Zhou X.F. Differential actions of neurotrophins on apoptosis mediated by the low affinity neurotrophin receptor p75NTR in immortalised neuronal cell lines. Neurochem. Int. 36:2000;55-65.
17. Larsen K.E., Fon E.A., Hastings T.G., Edwards R.H., Sulzer D. Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis. J. Neurosci. 22:2002;8951-8960.
18. Levi-Montalcini R. The nerve growth factor 35 years later. Science. 237:1987;1154-1162.
19. Levi-Montalcini R., Dal Toso R., della Valle F., Skaper S.D., Leon A. Update of the NGF saga. J. Neurol. Sci. 130:1995;119-127.
20. Mattson M.P., Zhang Y., Bose S. Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis, and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose. Exp. Neurol. 121:1993;1-13.
21. Rabizadeh S., Oh J., Zhong L.T., Yang J., Bitler C.M., Butcher L.L., Bredesen D.E. Induction of apoptosis by the low-affinity NGF receptor. Science. 261:1993;345-348.
22. Shaw K.P. Human methamphetamine-related fatalities in Taiwan during 1991-1996. J. Forensic Sci. 44:1999;27-31.
23. Stumm G., Schlegel J., Schafer T., Wurz C., Mennel H.D., Krieg J.C., Vedder H. Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons. FASEB J. 13:1999;1065-1072.
24. Wilson J.M., Kalasinsky K.S., Levey A.I., Bergeron C., Reiber G., Anthony R.M., Schmunk G.A., Shannak K., Haycock J.W., Kish S.J. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat. Med. 2:1996;699-703.